Kazia Therapeutics Ltd
ASX:KZA
Kazia Therapeutics Ltd
ASX:KZA
Price:
0.08 AUD
Market Closed
Updated:
May 2, 2024
Kazia Therapeutics Ltd
Cash from Financing Activities
|
Kazia Therapeutics Ltd
Cash from Financing Activities Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Kazia Therapeutics Ltd
ASX:KZA
|
Cash from Financing Activities
AU$13m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
16%
|
|
|
Immutep Ltd
ASX:IMM
|
Cash from Financing Activities
AU$76m
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Financing Activities
$67.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-8%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Financing Activities
-AU$2.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Financing Activities
AU$10.2m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kazia Therapeutics Ltd's Cash from Financing Activities?
Cash from Financing Activities
13m
AUD
13m
AUD
Based on the financial report for Jun 30, 2023, Kazia Therapeutics Ltd's Cash from Financing Activities amounts to 13m AUD.
What is Kazia Therapeutics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
16%
16%
Over the last year, the Cash from Financing Activities growth was 248%. The average annual Cash from Financing Activities growth rates for Kazia Therapeutics Ltd have been 2% over the past three years , and 16% over the past ten years .
You don't have any saved screeners yet
